This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Source of effectiveness data
The effectiveness data were derived from a single study.
Link between effectiveness and cost data
The resource use data were collected using patient questionnaires. These seem to have been distributed to the intervention group (teleophthalmology) during, or shortly after, the visit. The comparison group was included retrospectively, and the questionnaire could have been distributed to them up to a year after the visit to the university clinic took place.
Study sample
The study was a feasibility and pilot study, and so the number of patients included was not determined using power calculations. Thirty consecutive patients were invited to visit their local practice for examination using teleophthalmology, of which 29 agreed to participate in the study. These were compared with 41 consecutive patients from the same geographic area, who had visited the university glaucoma clinic one year earlier. Apart from age, no other baseline characteristics were given.
Sensitivity analysis
No sensitivity analysis was carried out.
Estimated benefits used in the economic analysis
This cost-consequence analysis did not present the benefits of treatment.
Cost results
The cost data were presented in two tables, which were difficult to interpret. The authors also used a bar chart to draw the conclusion that the intervention cost 550 FIM per case, when conducting 300 examinations per year. Finally, an unpublished source was cited as providing the evidence for a cost of $111 per clinic visit. The authors subsequently stated "Thus, when the higher travelling costs of the control are taken into account, the telemedicine visit saved approximately $55 per visit".
Synthesis of costs and benefits
Not applicable.
Authors' conclusions
This study was undertaken as a pilot project to undertake a preliminary assessment of a teleophthalmology-based investigation technology. The authors commented that the patient satisfaction with teleophthalmology was high, and that there may be cost-savings associated with the technology. However, the authors emphasised that the study groups may not have been comparable, and that the quality of the assessment images was not comparable between the eyeclinic and teleophthalmology groups. Further, the authors commented that the equipment was not user-friendly. Therefore, they concluded that further research is needed to assess the clinical and cost consequences of teleophthalmology.
CRD COMMENTARY -Selection of comparators
Teleophthalmology was compared with attending an eye clinic. A visit to an eye clinic represents current practice, and was therefore an appropriate comparator.
Validity of estimate of measure of effectiveness
The measure of effectiveness, in terms of satisfaction with treatment, was derived from patient questionnaires. It was unclear when these questionnaires were distributed to the patients. This may have played a role in the assessment of the comparator group, since these patients underwent treatment one year prior to the study and, therefore, may have had a longer time in which to make the assessment. This, in turn, may have resulted in recall bias. It is not ideal to compare a treatment group with historical controls. Indeed, the authors acknowledged that the estimated difference in patient satisfaction might have been due to a systematic difference in the delivery of care in the context of the study (the teleophthalmology group) and regular clinical practice (the eye clinical group). It is therefore difficult to assess whether the estimates are valid.
Validity of estimate of measure of benefit
There was no summary measure of benefit.
Validity of estimate of costs
The resource use was reported separately from the unit costs. The resource use was also assessed through patient questionnaires. Thus, the limitations identified with the effectiveness estimate also apply to the cost estimate. One additional problem is that the sources of the unit costs were not reported. Also, the method of presentation meant that it was impossible to determine the relationship between the final costs and the cost components. Finally, it seems like that
